Damora Therapeutics Inc (Pre-Reincorporation) <DMRA.O>: Wedbush raises target price to $40 from $35
DMRA•Related News
ICE to buy MarketAxess for USD 167 a share in cash valuing deal at USD 6 billion
MKTX•
Netlist Q2 revenue rises, swings to profit
NLST•
MarketAxess Q2 revenue slightly beats estimates; to be acquired by Intercontinental Exchange
MKTX•
Winchester Bancorp returns to profit in FY26, posts net income of $4.4 million
WSBK•
Leonardo DRS Q2 revenue beats on higher tactical radars demand
DRS•